BioLineRx(BLRX) - 2025 Q4 - Earnings Call Transcript

BioLineRx (NasdaqCM:BLRX) Q4 2025 Earnings call March 23, 2026 08:30 AM ET Company ParticipantsElla Sorani - Chief Development OfficerIrina Koffler - Investor Relations OfficerMali Zeevi - CFOPhilip Serlin - CEOConference Call ParticipantsJoe Pantginis - Managing Director and Equity Research AnalystJohn Vandermosten - Senior AnalystJustin Walsh - AnalystOperatorLadies and gentlemen, thank you for standing by. Welcome to the BioLineRx fourth quarter and full year 2025 financial results conference call. All p ...